The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Carnegie Surgical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Carnegie Surgical is a medical technology company that specializes in providing innovative solutions for the surgical industry. The company provides custom manufacturing original equipment manufacturing of private label solutions for a broad range of surgical instruments. It products include dental instruments, ear and nose instruments, specialty instruments for general, plastic surgery, retractor systems, and sterile ENT surgery and anaesthesia products. It also offers customized manufacturing of specialty instruments for ENT, general, plastic surgery, and anaesthesia. Carnegie Surgical is headquartered in East Windsor, New Jersey, the US.
The key metrics of Carnegie Surgical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Carnegie Surgical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Carnegie Surgical.
For a detailed understanding of the performance of Carnegie Surgical, buy the report here.